fetching data ...
version:
1.02
Home
Search:
Free Text Search
List:
Abstract Titles
Sessions
Authors
Keywords
Bookmarks
Include in search:
all years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
List: Sessions
Go!
Years:
2026 (London, England)
Total Number of items found:
186
in
19
pages.
Goto page:
10
50
100
Jump to page containing Sessions starting with :
A
B
C
E
H
I
K
L
M
N
P
R
S
T
W
Sessions
[8]
Abstract Plenary
2026
2026 OP001
TREAT−TO−TARGET CONTINUATION OF URATE−LOWERING THERAPY VERSUS A URATE−LOWERING THERAPY DISCONTINUATION ATTEMPT STRATEGY IN GOUT PATIENTS IN REMISSION (GO TEST FINALE): A PRAGMATIC OPEN LABEL RANDOMISED SUPERIORITY TRIAL.
,
I. R. Peeters, A. A. den Broeder, M. H. M. Wientjes, N. den Broeder, A. C. D. Peeters, L. Joosten, D. den Uyl, T. Jansen, M. Smits, L. van Bon, P. H. P. de Jong, H. E. Vonkeman, M. L. Oudemans, W. Taylor, C. van Durme, W. Y. Kwok, H. J. Schers, M. Flendrie, N. van Herwaarden
2026 OP002
ANIFROLUMAB TREATMENT IN PATIENTS WITH SJÖGREN’S DISEASE: EFFICACY AND SAFETY ASSESSMENT IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA PROOF-OF-MECHANISM TRIAL (ANISE-II)
,
H. Bootsma, N. S. Ausma, L. de Wolff, G. S. van Zuiden, A. J. Stel, L. Olie, K. Delli, J. Alberga, F. K. L. Spijkervet, F. G. M. Kroese, B. van der Vegt, A. Vissink, G. M. Verstappen, S. Arends
2026 OP003
MICROENVIRONMENTAL HYPOXIA AND HIF-1α ACTIVITY SEGREGATE ACROSS SKIN, SYNOVIUM AND ENTHESIS IN PSORIATIC DISEASE AND ASSOCIATE WITH COMPARTMENT-SPECIFIC CD8 EXHAUSTION.
,
D. Mauro, M. G. Raimondo, A. Ciancio, G. Forte, H. Mohammadian, S. Gandolfo, G. Ilardi, R. Giacca, M. Raimondi, A. Salzillo, K. Ali, G. Cincinelli, A. Parafioriti, R. F. Caporali, A. Ramming, F. Ciccia
2026 OP004
MULTI-OMICS ANALYSIS ELUCIDATES THE TRAJECTORY OF PROGRESSION FROM THE ANTIBODY-POSITIVE PHASE TO ESTABLISHED SYSTEMIC SCLEROSIS
,
H. Yin, F. Wu, C. Jia, W. LIN, Z. Zhao, D. ZHE, Y. Sun, C. Wei, X. Liu, L. Lu
2026 OP005-HPR
COST-EFFECTIVENESS OF DIGITAL PATIENT EDUCATION FOR NEWLY DIAGNOSED PATIENTS WITH RHEUMATOID ARTHRITIS: AN ECONOMIC EVALUATION FROM A RANDOMISED CONTROLLED TRIAL
,
L. Raunsbæk Knudsen, A. Wiben, C. Skovsgaard, M. Ndosi, E. M. Hauge, K. Lomborg, L. W. Dreyer, L. Sørensen, A. de Thurah
2026 OP006
LUPUS NEPHRITIS HISTOLOGICAL ACTIVITY AND RESPONSE ARE LINKED TO SPECIFIC IMMUNE, METABOLIC, AND REMODELING PATHWAYS: A PER-PROTOCOL KIDNEY BIOPSY STUDY.
,
A. Fava, C. Y. Lee, R. Lu, C. Guthridge, R. Chou, D. Nikolopoulos, J. Lindblom, F. Tamirou, J. A. James, M. Petri, J. M. Guthridge, F. Houssiau, I. Parodis
2026 OP007-PARE
PRESENCE AND IMPACT OF INVOLVEMENT IN ARTHRITIS UK FUNDED RESEARCH
,
G. Winsor, S. Rudkin, S. Yorke
2026 OP008
CD19 CAR T-CELL THERAPY IN ACPA-POSITIVE, TREATMENT-REFRACTORY, ACTIVE RHEUMATOID ARTHRITIS - DATA FROM THE PHASE 1 OF THE PROSPECTIVE, INTERVENTIONAL COMPARE TRIAL
,
F. N. Albach, M. L. Hütter-Krönke, M. Rehm, M. Torgutalp, T. H. Le, I. Minopoulou, A. Wilhelm, A. Sattler, J. Verhagen, R. Biesen, N. M. Drzeniek, E. Wiebe, A. Fleischmann, V. Casteleyn, V. Scholz, T. Witte, T. Alexander, C. Furth, J. Zernicke, B. Muche, S. Hermann, H. U. Scherer, R. Toes, M. Nuesch-Germano, A. Pankow, S. Schallenberg, N. Unterwalder, A. Pfeil, E. Phithak, M. Krusche, O. Penack, W. Stenzel, M. Wuhrer, K. Movassaghi, E. Schrezenmeier, T. Vogl, U. Schneider, A. Busse, G. Schett, U. Keller, L. Bullinger, A. Kleyer, G. Krönke, D. Simon
[1]
Advancing Global Health in Rheumatology: Building Capacity, Equity, and Resilience Across Borders
2026
2026 OP029
INEQUITIES IN GLOBAL REPRESENTATION AND TRANSPARENCY IN TRANSCRIPTOMIC STUDIES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A SYSTEMATIC ASSESSMENT OF PUBLIC DATASETS
,
R. Martinez-Canales, M. Montelongo Rojas, L. Perez-Barbosa, D. Rodriguez-Garibay, B. R. Avalos García, C. M. Skinner-Taylor, D. A. Galarza-Delgado, M. C. Salinas-Carmona, N. Macias-Segura
[8]
Basic Abstract Sessions: Decoding the Immune System - OMICS and beyond
2026
2026 OP0257
SPATIAL TRANSCRIPTOMICS REVEALS MECHANISM OF AUTOIMMUNITY DRIVEN BY INTERNALIZED AUTOANTIBODIES
,
I. Pinal-Fernandez, K. Pak, M. Casal-Dominguez, S. Muñoz-Braceras, G. Wigerblad, S. Del Orso, F. Naz, S. Islam, G. Gutierrez-Cruz, T. B. Kinder, S. A. Ogbonnaya-Whittlesey, A. Fernández-Codina, M. Giannini, B. Ellezam, G. Laverny, V. Gilbart, O. Landon-Cardinal, M. Hudson, Y. troyanov, D. Randazzo, A. Kenea, A. Matas-García, G. Garrabou, I. Aldecoa-Ansorregui, A. Gil, E. Trallero-Araguás, M. Milone, T. Liewluck, E. Naddaf, G. Espinosa, C. P. Simeón-Aznar, A. Guillen-Del-Castillo, C. Preuße, F. Kleefeld, N. Bublitz, W. Stenzel, A. Meyer, J. Pope, A. Selva-O’Callaghan, J. Milisenda, A. Mammen
2026 OP0258
LONGITUDINAL SERUM PROTEOMIC SIGNATURES ASSOCIATED WITH DURABLE REMISSION VERSUS RELAPSE AFTER CAR-T THERAPY IN AUTOIMMUNE DISEASES
,
F. Iwata, P. G. Gavin, D. M. Nöthling, K. Anoshkin, L. Bucci, P. Garantziotis, S. Clarke, N. Ferrari, C. Tur, M. Hagen, A. Wirsching, T. Rothe, S. Kretschmann, S. Völkl, M. Aigner, F. Müller, A. Mackensen, A. Bozec, G. Schett, R. Grieshaber-Bouyer
2026 OP0259
SHARED AND DISEASE-SPECIFIC MOLECULAR SIGNATURES IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS REVEALED BY MULTI-OMICS INTEGRATION
,
I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, M. Á. Aguirre-Zamorano, E. Moreno-Caño, L. Formanti Alonso, R. Ortega-Castro, C. Aranda-Valera, M. L. Ladehesa-Pineda, J. Calvo-Gutiérrez, D. Ruiz-Vilchez, C. Merlo, N. Barbarroja, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera, T. Cerdó
2026 OP0260
ASSOCIATIONS OF CLINICAL BIOMARKER- AND PROTEOMIC-BASED BIOLOGICAL AGING WITH AUTOIMMUNE DISEASE INCIDENCE AND LIFE EXPECTANCY
,
M. Song, C. Yun
2026 OP0261
STIMULATED EMISSION DEPLETION (STED) MICROSCOPY FOR ANA PATTERN IDENTIFICATION: FIRST DATASET AND MACHINE LEARNING COMPARISON WITH FLUORESCENCE MICROSCOPY
,
K. Wójcik, A. Drynda, P. Kulakowski, P. Sosna, J. Wilańska, M. Sanak, O. Adamczyk, N. Pocałuń, K. Solarczyk, P. Kasprzycki, O. Szelest
2026 OP0262
IMMUNOMETABOLIC CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PATIENTS WITH cSLE AND JDM TREATED WITH ANTI-CD19 CAR T CELLS
,
E. Marasco, A. Ariolli, N. de Franco, R. Nicolai, C. Bracaglia, S. Barresi, M. Becilli, P. Merli, M. I. Petrone, F. del Bufalo, M. Algeri, M. G. Cefalo, F. Locatelli, F. de Benedetti
2026 OP0263
DYNAMICS OF THE IMMUNE CELL SIGNATURE ASSOCIATED WITH THE DEVELOPMENT OF IMMUNE-RELATED ADVERSE EVENT: RESULTS FROM LONGITUDINAL IMMUNE PROFILING
,
C. Jiana, J. Xu, M. Wang, Z Zhou, X. Si, L. Zhang, N. Liang, X. Jiang, H. Yang
2026 OP0264
MULTI-TISSUE TRANSCRIPTOMICS ANALYSIS OF EARLY CTD-ILD REVEALS CONSISTENT MOLECULAR SIGNATURES POINTING TO INTERFERON RESPONSE MECHANISMS
,
P. Stauffer, V. Palchevskiy, L. Much, P. P. Diep, M. M. Aabel, N. Moe, T. Gaisl, C. Steinack, S. Lari, E. Pachera, Ø. Molberg, O. Distler, S. S. Weigt, J. Belperio, A. M. Hoffmann-Vold
[8]
Basic Abstract Sessions: Digging deep into Lupus
2026
2026 OP0148
PLATELETS ACTIVATE REMIGRATING NEUTROPHILS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND REPRESENT A THERAPEUTIC TARGET
,
Y. Fu, R. Karali, M. Nansion, E. Schmauch, P. Vacher, J. Sibilia, P. Grenot, A. S. Korganow, T. Martin, S. Caillard, A. Duval, J. Olagne, J. E. Gottenberg, R. Carapito, S. Bahram, P. Blanco, M. Scherlinger
2026 OP0149
CLONALLY EXPANDED DURAL CD8+ T CELLS DRIVE PATHOLOGICAL LYMPHATIC REMODELING VIA MACROPHAGE CROSSTALK IN NEUROPSYCHIATRIC SLE
,
Y. Feng, Z. He, S. Li, N. Chen, C. Zhou, J. Pan, Q. Huang, L. Jie
2026 OP0150
AUTOANTIBODY SIGNATURES FOR RISK STRATIFICATION OF ATHEROSCLEROSIS PROGRESSION AND STATIN RESPONSE IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
,
J. Peng, P. Donnes, T. McDonnell, S. Ardoin, L. Schanberg, L. Lewandowski, E. Jury, G. Robinson, C. Ciurtin
2026 OP0151
SINGLE-CELL ANALYSIS OF INTERFERON BLOCKADE UNCOVERS B CELL REPERTOIRE REMODELING IN SYSTEMIC LUPUS ERYTHEMATOSUS
,
K. Terada, Y. Tsuchida, T. S. Ushijima, Y. Suwa, K. Saegusa, S. Yamada, M. Ota, T. Okamura, K. Fujio
2026 OP0152
IMMUNE RESET AND MICROBIAL SHIFTS: GUT MICROBIOTA DYNAMICS AFTER CD19 CAR T-CELL THERAPY IN AUTOIMMUNE DISEASE
,
Y. Maeda, I. Gimaev, S. Redanz, E. Schmid, N. Otterbein, M. Hagen, A. Wirsching, T. Rothe, S. Wirtz, R. Grieshaber-Bouyer, F. Müller, M. Aigner, S. Völkl, A. Mackensen, T. Vogl, I. Brito, G. Schett, M. Kriegel, M. M. Zaiss
2026 OP0153
12-LIPOXYGENASE REGULATES INFLAMMATORY CELL RECRUITMENT IN LUPUS NEPHRITIS
,
M. Monteil, I. Allaeys, T. Lévesque, K. Greffard, I. Tsukayama, J. F. Bilodeau, P. Fortin, E. Boilard
2026 OP0154
OXIDATIVE STRESS–ASSOCIATED PLA2 ACTIVATION DRIVES LYSOPHOSPHOLIPID DYSREGULATION LINKED TO B CELL HYPERACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
,
J. Huang, J. Yang, X. Han
2026 OP0155
EARLY DISRUPTION OF B CELL TOLERANCE PATHWAYS AND IMMUNE REGULATORY CIRCUITS IN PRECLINICAL SYSTEMIC AUTOIMMUNE DISEASE
,
A. Bylinska, M. Smith, R. Lu, C. Wagner, B. Jones, M. C. Marlin, C. Guthridge, C. Wright, S. Macwana, W. DeJager, M. Beel, C. J. Lessard, C. Arriens, T. Aberle, J. Merrill, J. M. Guthridge, J. A. James
[8]
Basic Abstract Sessions: Hidden circuits in Psoriatic Arthritis and Spondylarthritis
2026
2026 OP0265
DYNAMIC ORCHESTRATION OF Th17, TRM, AND MAIT CELLS LINKS THE GUT–JOINT AXIS DURING SPONDYLOARTHRITIS DEVELOPMENT IN THE SKG Model
,
F. Verhoeven, L. Guet, B. Favier, X. Romand, C. Demougeot, D. Wendling, C. Prati, A. Baillet, D. HANNANI
2026 OP0266
SINGLE-CELL PROFILING OF SKIN AND SYNOVIAL FIBROBLASTS IDENTIFIES OPPOSING IFN ALPHA/BETA PATHWAY REGULATION IN PSORIASIS WITH ARTHRALGIA AND PSORIATIC ARTHRITIS.
,
A. Khmelevskaia, L. A. Coletto, D. Somma, S. Alivernini, M. Kurowska-Stolarska, C. Ospelt, R. Micheroli
2026 OP0267
UNCOVERING A CRITICAL ROLE FOR MALT1 IN TNF-DRIVEN ARTHRITIS AND ILEITIS
,
E. Gilis, J. Coudenys, J. Staal, R. Beyaert, D. Elewaut
2026 OP0268
A T CELL-DRIVEN CCL20+ MACROPHAGE CIRCUIT DRIVES TNF PATHOLOGY AND Th17 Cell Recruitment In Axial Spondyloarthritis Synovium
,
J. Zhao, F. Liu, J. Li, H. Shi, C. Worth, L. Jiang, D. Simone, F. Penkava, A. Chan, L. Duan, P. Bowness, L. Chen
2026 OP0269
THE HEXOSAMINE BIOSYNTHESIS PATHWAY DRIVES LIGAMENT HETEROTOPIC OSSIFICATION VIA PROTEIN O-GlcNAcylation IN r-axSpA
,
K. tang, L. Zu, C. Wu, D. Zhuo, J. Wang, J. Liu
2026 OP0270
CIRCULATING PRE-OSTEOCLASTS ARE PRIMED FOR OSTEOCLAST FATE AND SYNOVIAL TISSUE HOMING IN PSORIATIC ARTHRITIS.
,
J. Hutton, A. Saha, Q. Li, N. Farahi, F. Leek, S. McDonnell, B. Ade-Ojo, D. Gillett, N. Shenker, D. Jadon, A. Ladach, C. Summers, N. McGovern
2026 OP0271
AN IL-7–DRIVEN GLUCOSE–AIOLOS METABOLIC CIRCUIT LICENSES PATHOGENIC CD8
+
T CELLS IN SPONDYLOARTHRITIS
,
M. Akiyama, W. Alshehri, M. Koroyasu, T. Kaburaki, K. Yoshimoto, K. Saito, K. Shimanuki, Y. Kaneko
2026 OP0272
NSD1, H3K36me1/2 METHYLTRANSFERASE AS A POTENTIAL THERAPEUTIC TARGET IN TH17 CELL-MEDIATED AUTOINFLAMMATORY DISEASE
,
S. E. Wang, D. T. Kim, J. S. Joo, S. H. Lee, J. Chin, S. Jo, J. Y. Hong, T. H. Kim
[8]
Basic Abstract Sessions: New therapeutic targets in Rheumatoid Arthritis and Sjögren’s
2026
2026 OP0156
OFF-THE-SHELF DUAL-CAR T-CELL THERAPY: TARGETING B AND T CELLS IN AUTOIMMUNE DISEASE WITHOUT PRECONDITIONING
,
N. J. Shiff, M. Jelcic, S. Chandra, S. Shirinbak, B. Groff, A. Williams, A. Gutierrez, M. Meza, B. Gaertner, K. Palomares, L. Campanati, C. Dege, P. F. Tsai, T. Lee, R. Clarke, K. J. Malmberg, M. Mamonkin, B. Valamehr, V. Sandhu, A. Garcia, J. Goodridge, M. Hosking
2026 OP0157
KT502, A NOVEL CD19-DIRECTED T CELL ENGAGER, LEADS TO RAPID AND DEEP B CELL DEPLETION WITH TRANSIENT AND LOW CYTOKINE RELEASE
,
M. Bao, J. Wang, J. Zhao, W. Xu
2026 OP0158
CALCIUM PHOSPHATE-ASSOCIATED EXTRACELLULAR VESICLES IN RHEUMATOID ARTHRITIS
,
C. Schmidt, F. Wagner, P. Engelhard, L. Cordruwisch, L. Uhlmann, A. M. Glimm, M. Pierer, U. Wagner
2026 OP0159
MULTIMODAL ANALYSIS IDENTIFIES ALTERED BRAIN CONNECTIVITY SIGNATURE AND RELATED PSYCHOLOGICAL AND MOLECULAR PATTERNS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
,
L. Gunkl-Tóth, G. Orsi, N. Császár-Nagy, L. Duzsik, G. Mátay, K. Csókási, G. Sütő, G. Kumánovics, S. Takács, Z. Vidnyánszky, J. Kun, K. Takács-Lovász, A. Pintér, P. Királyhidi, G. Schett, G. Nagy, Z. Helyes
2026 OP0160
ENHANCED TYK2 INHIBITION SIGNATURE IS ASSOCIATED WITH SEVERITY OF CLINICAL DOMAINS AND LABORATORY MEASURES IN SJÖGREN’S DISEASE
,
B. Johnson, J. Bumgarner, S. Li, C. Wu, M. Bombardieri, E. Pontarini, X. Mariette, D. Cornec, J. Liu
2026 OP0161
ACCUMULATION OF MITOCHONDRIAL dsRNA DUE TO DEFECTIVE m
6
A-DEPENDENT RNA REGULATION IN EPITHELIAL CELLS MAY EXPLAIN THE INTERFERON SIGNATURE IN SJÖGREN’S DISEASE
,
A. Arco-Hierves, K. Pamboukas, L. Mutala, L. S. Borowski, C. Mayet, P. Mazet, S. E Silva-Saffar, L. Askenatzis, J. Pascaud, P. Labrot, C. Lasgi, A. Navickas, T. Naninck, N. Seddiki, R. Szczęsny, G. Nocturne, X. Mariette, R. Bechara
2026 OP0162
DIRECT INHIBITION OF SALIVARY GLAND ORGANOID MATURATION BY IGG FROM SJÖGREN DISEASE PATIENTS
,
T. D. Steinmetz, A. Wolthuis, T. Yang, J. H. Terpstra, B. Plaat, J. Alberga, F. G. M. Kroese, H. Bootsma, S. Pringle
2026 OP0163
EVIDENCE OF THE DUAL MECHANISM OF ACTION OF IANALUMAB (VAY736) IN THE CIRCULATION AND SALIVARY GLAND TISSUE OF PATIENTS WITH SJÖGREN’S DISEASE: RESULTS FROM A PHASE 2 MECHANISTIC STUDY
,
D. Cornec, R. Hillenbrand, P. Hémon, M. Le Rochais, D. Saldana Miranda, A. Santos da Costa, M. Frutoso, C. Iperi, C. Cao, C. Le Dantec, U. Sommer, T. Shekarian, A. Uguen, C. Jamin, P. Baley, C. Denis, D. Guellec, A. Tison, D. Strasser, S. Jousse-Joulin, S. Chen, N. Giglioli, C. Sips, I. Isnardi, S. Barman, E. Ferrero, N. Eling, G. Wieczorek, A. Saraux, R. Siegel, W. Hueber, S. Hillion, V. Devauchelle-Pensec, C. Bonal
[8]
Basic Abstract Sessions: Novel Mechanisms in Rheumatoid Arthritis development and progression
2026
2026 OP0273
ENRICHMENT OF T PERIPHERAL HELPER CELLS IN BOTH ORGANIZED AND DIFFUSE IMMUNE INFILTRATES IN RA-ILD LUNG EXPLANTS.
,
A. Seng, K. Suga, A. Singaraju, B. E. R. Samuel, Y. J. Choi, J. Fert-Bober, J. Giles, T. Parimon, P. Chen, N. Bottini
2026 OP0274
Piezo2 DRIVES Rab11FIP1-DEPENDENT VESICULAR TRAFFICKING OF RANKL IN FIBROBLAST-LIKE SYNOVIOCYTES: A NOVEL MECHANO-IMMUNOLOGICAL AXIS DRIVING BONE DESTRUCTION IN RHEUMATOID ARTHRITIS
,
Y. Lu, T. Wu, Z. M. OuYang, Y. T. Fan, X. B. Lin, Y. W. Zou, Y. Yang, Y. Q. Mo, H. Sun, J. D. Ma, L. Dai
2026 OP0275
RHEUMATOID ARTHRITIS MODULATES IMMUNE CELL TRAJECTORIES ACROSS PREGNANCY
,
B. Goulden, B. van Heeswijk, H. Cross, L. F. Perez, E. Röder, E. Lubberts, E. Jury, G. Robinson, R. J. E. M. Dolhain, I. Giles
2026 OP0276
THE EMERGENCE OF DISTINCT CD8
+
T CELL EFFECTOR PHENOTYPES IS ASSOCIATED WITH SUBCLINICAL SYNOVITIS WHEN RHEUMATOID ARTHRITIS IS IMMINENT
,
K. Abacar, F. Tariq, P. Martin, W. Ye, X. Sun, S. MacKay, D. Muldoon, L. Duquenne, A. Di Matteo, K. Harnden, K. Mbara, M. Menon, H. Al-Mossawi, M. Buch, P. Emery, D. Newton, B. Fairfax, K. Mankia
2026 OP0277
RECENT THYMIC EMIGRANTS DEFINE A THERAPEUTICALLY MODIFIABLE IMMUNOMETABOLIC STATE IN RHEUMATOID ARTHRITIS
,
Z. Yang, P. Pietzcker, F. V. Kraus, J. Lu, R. Song, L. V. Klotz, K. Gente, R. A. Carvalho, H. M. Lorenz, M. Souto-Carneiro
2026 OP0278
ROSNILIMAB SELECTIVELY DEPLETES PATHOGENIC T CELLS AND DOWNREGULATES CLINICALLY RELEVANT IMMUNE PATHWAYS IN RHEUMATOID ARTHRITIS: A TRANSLATIONAL ANALYSIS OF BLOOD AND SYNOVIAL TISSUE FROM THE RENOIR PHASE 2B TRIAL
,
C. Aversa, Y. Ren, M. Dahl, E. Hare, P. Lizzul, C. Pitzalis, C. Sibley
2026 OP0279
GENETIC RISK VARIANTS REVEAL CYTOKINE-RESPONSIVE MODULES DRIVING PATHOGENIC PROGRAMS IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS
,
E. Ezen, A. Khmelevskaia, M. Lugar, C. Ospelt
2026 OP0280
POPULATION-SCALE T-CELL RECEPTOR SEQUENCING IN RHEUMATOID ARTHRITIS CONTROLS HLA POLYMORHISM AND IDENTIFIES DISEASE-ASSOCIATED CLONOTYPES
,
T. Nishino, T. Arakawa, R. Sasai, K. Asahara, H. Inokuchi, N. Itokawa, M. Yamaguchi, M. Endo, S. Noma, T. Kawashima, H. Hatano, M. Nakano, M. Kono, B. Natsumoto, K. Matsuda, Y. Momozawa, K. Ishigaki
[8]
Basic Abstract Sessions: The Many Paths of Arthritis
2026
2026 OP036
NETWORK ANALYSIS OF THE SERUM PROTEOME IN A PROSPECTIVE COHORT OF IMMUNE CHECKPOINT INHIBITOR RECIPIENTS HIGHLIGHTS INTERFERON-γ AS A PIVOTAL MEDIATOR OF IMMUNE-RELATED ADVERSE EVENTS
,
J. Berry, K. Williams, A. Gault, L. Hogarth, A. Degnan, J. Diboll, I. Wilson, A. E. Anderson, R. Plummer, A. Pratt
2026 OP037
IMMUNE EXHAUSTION PROTECTS AGAINST CHECKPOINT INHIBITOR TOXICITY CAUSED BY ACTIVATION AND MIGRATION OF CYTOTOXIC T-CELLS TO SYNOVIAL TISSUE
,
A. K. McLean, A. Thomson, J. D. Turner, K. Williams, A. C. Gault, A. Degnan, J. Berry, L. Hogarth, J. Diboll, I. Nicorescu, L. J. Jones, G. Merces, A. Teodosio, B. Hunter, I. Wilson, A. Bridgewood, L. J. Brown-Schofield, J. Nsengimana, S. Jariwala, Q. An, L. Pallan, B. A. Fisher, J. Coxhead, R. Hussain, M. Magid-Slav, D. McDonald, S. Siebert, A. Filby, A. P. Croft, J. Isaacs, G. Reynolds, R. Plummer, C. Hilkens, D. F. Tough, A. E. Anderson, A. Filer, A. Pratt
2026 OP038
PLASMA PROTEOMIC PROFILE OF RHEUMATOID ARTHRITIS: INSIGHTS INTO SHARED INFLAMMATORY PATHWAYS WITH PSORIATIC ARTHRITIS
,
M. Kyriakidi, E. K. Vetsika, G. E. Fragoulis, M. G. Tektonidou, P. P. Sfikakis
2026 OP039
CCR2-GUIDED TREG EXOSOME–GAS6 HYBRID SYNERGISTICALLY REPROGRAMS MACROPHAGE INFLAMMATION AND IMMUNE TOLERANCE IN GOUTY ARTHRITIS
,
芳. 陈
2026 OP040
JAK-DEPENDENT REGULATION OF CXCL10, A KNOWN NOCICEPTIVE CHEMOKINE, IDENTIFIES A POTENTIAL TARGET UNDERLYING PAIN REDUCTION IN AN IN VITRO MODEL OF ENTHESITIS
,
F. Trunfio, T. Macleod, A. Tonutti, M. Harland, C. Wong, K. Abacar, R. Dunsmuir, N. Adsul, A. S. Rao, V. Borse, T. McMillan, M. Vomero, P. Loughenbury, L. Navarini, R. Giacomelli, A. Altaie, D. McGonagle
2026 OP041
FENESTRATED CAPILLARIES AS THE STRUCTURAL BASIS OF THE BLOOD–JOINT BARRIER
,
T. Hasegawa, N. Morone
2026 OP042
EARLY INTERVERTEBRAL BONE FORMATION IN RECENT-ONSET ARTHRITIS REVEALED BY X-RAY PHASE-CONTRAST IMAGING: EVIDENCE FOR PARALLEL, NON-SEQUENTIAL BONE AND INFLAMMATORY PROCESSES
,
F. Verhoeven, C. Olivier, S. Aubry, S. Hecquet, C. Viennet, P. Totoson, X. Romand, A. Baillet, L. Broche, D. Wendling, C. Demougeot, C. Prati, E. Brun
2026 OP043
TRANSCRIPTOMIC PROFILES DIFFERENTIATE RESOLVING FROM CHRONIC REACTIVE ARTHRITIS
,
A. Agarwal, P. Dhanekula, S. Verma, S. R. Nayak, P. Mruthyunjaya, P. Padhan, A. R. K. Patro, R. Misra, S. Ahmed
[8]
Basic Abstract Sessions: Understanding how the vessel burns
2026
2026 OP0281
NR2C1 DOWNREGULATION IMPAIRS REGULATORY T CELL DIFFERENTIATION AND CONTRIBUTES TO IMMUNODYSREGULATION IN BEHÇET’S DISEASE
,
Y. Liu, J. Wu, X. Yu, X. Wang, H. Chen, W. Zheng
2026 OP0282
VSMCS-DERIVED IL-33 INDUCES A Th1-LIKE PHENOTYPE IN CD4+ STEM-LIKE T CELLS AND CONTRIBUTES TO ARTERIAL WALL INFLAMMATION IN TAKAYASU’S ARTERITIS
,
C. Fang, L. Du, S. Gao, Z. Chen, Y. Li
2026 OP0283
IMPACT OF IL-17A On Synovial Fibroblast From Subacromial Bursae
,
A. Ramon, H. Greigert, B. Lamarthée, C. Richard, A. Varin, C. Cladière, N. Kloppfenstein, L. Labattut, A. Bordet, S. Audia, R. Boidot, J. F. Maillefert, P. Ornetti, B. Bonnotte, M. Samson
2026 OP0284
SINGLE-CELL TRANSCRIPTOMIC AND PROTEOMIC PROFILING HIGHLIGHTS THE ROLE OF GZMK+ CD8+ T CELLS IN SEVERE VASCULAR BEHÇET’S SYNDROME
,
J. Li, S. Jin, T. Liu, Z. Li
2026 OP0285
GM-CSF- AND IFN-Γ-PRODUCING T CELLS IN POLYMYALGIA RHEUMATICA
,
A. Zhang, W. Abdulahad, W. F. Jiemy, R. Reitsema, Y. van Sleen, M. Sandovici, A. Diepstra, T. Kwee, C. Roozendaal, P. Heeringa, E. Brouwer, K. van der Geest
2026 OP0286
B CELL RECEPTOR ISOTYPES OF CIRCULATING PR3-SPECIFIC AUTOREACTIVE B CELLS IN ANCA-ASSOCIATED VASCULITIS
,
G. Boscato Sopetto, V. Facchini, R. Corbellari, A. Mattè, I. Pesce, A. Hummel, S. Hillion, M. F. Konig, M. Pandey, G. Grandi, D. Cornec, U. Specks, A. Berti
2026 OP0287
SINGLE-CELL ANALYSIS REVEALS GLYCOSYLATION-DYSREGULATED NAÏVE B CELLS IN IgA VASCULITIS
,
J. C. Batista-Liz, M. Sebastián Mora-Gil, E. Troendle, O. Cappa, M. T. Leonardo Cabello, A. C. Peñalba Citores, L. Martín-Penagos, L. Gabrie, R. Gálvez-Sánchez, J. L. Callejas, D. de Argila, E. Vicente-Rabaneda, S. Castañeda, D. Simpson, R. Blanco, V. Pulito-Cueto, R. López-Mejías
2026 OP0288
APREMILAST SUPPRESSES MONOCYTE-DRIVEN INFLAMMATION BY TARGETING BACH1 IN BEHÇET’S DISEASE
,
Y. Liu, J. Wu, Y. Ao, X. Yu, J. Liu, W. Zheng
[8]
Basic and Clinical Abstract Session: Beyond Hyperuricemia - New Insights into Gout Detection
2026
2026 OP0289
MUSCULOSKELETAL ULTRASOUND FINDINGS IN ASYMPTOMATIC HYPERURICEMIA: BASELINE ANALYSIS FROM THE TRANSITIONS IN GOUT RESEARCH (TIGER) STUDY USING THE OMERACT GOUT ULTRASOUND SEMI-QUANTITATIVE SCORING SYSTEM
,
S. Stewart, G. Gamble, W. Taylor, A. Harrison, T. Merriman, B. Mihov, A. Horne, I. Su, A. D. Tabi-Amponsah, L. Stamp, J. Haslett, T. Pascart, M. Andres, M. L. Peral-Garrido, T. Neogi, E. Norkuviene, J. Vazquez Mellado, J. D. Fitzgerald, L. Terslev, H. B. Hammer, T. Uhlig, M. A. D’Agostino, J. Martin, M. Sun, C. Li, N. Dalbeth
2026 OP0290
ASSOCIATION BETWEEN RECENT GOUT FLARE AND TACHYARRHYTHMIA IN PEOPLE WITH GOUT IN ENGLAND AND SWEDEN. NESTED CASE-CONTROL AND SELF-CONTROLLED CASE-SERIES ANALYSES
,
E. Cipolletta, T. Zverkova Sandström, G. Nakafero, D. Rozza, P. Drivelegka, G. Moroncini, A. Avery, L. Tata, M. Mamas, M. Dehlin, A. Abhishek
2026 OP0291
ESTRADIOL FACILITATES URATE EXCRETION BY REDUCING GLUT9 EXPRESSION VIA ERΒ/TMEM106B/PI3K/AKT1 PATHWAY IN RENAL TUBULAR EPITHELIAL CELLS
,
L. Haijun, X. Zizi, Y. Liu, K. Long, L. Nemin, W. Xiaomin
2026 OP0292
PRESENCE OF CRYSTAL DEPOSITIONS IN THE FIRST METATARSOPHALANGEAL JOINT IS CLOSELY RELATED TO LOCAL EROSIONS; RESULTS FROM THE 5-YEAR NOR-GOUT STUDY
,
H. B. Hammer, L. F. Karoliussen, L. Terslev, E. A. Haavardsholm, T. Uhlig
2026 OP0293
ASSOCIATION BETWEEN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TREATMENT AND KIDNEY IMPAIRMENT IN GOUT AND TYPE 2 DIABETES
,
Z. Wu, X. Li, N. Dalbeth, Y. Zhang, C. Li, K. Zhao, C. Zeng, G. Lei, Y. Cui, J. Wei
2026 OP0294
A PHASE 4, RANDOMIZED, DOUBLE-BLIND, MULTICENTER NON-INFERIORITY TRIAL EVALUATING THE EFFICACY AND SAFETY OF INTRAVENOUS PEGLOTICASE ADMINISTERED EVERY 4 WEEKS VS EVERY 2 WEEKS WITH WEEKLY METHOTREXATE
,
A. Majjhoo, O. M. Troum, C. Boomershine, S. Verma, F. Fang, J. Ji, Q. Yang, B. LaMoreaux, A. Gabriel
2026 OP0295
POLYSTYRENE MICROPLASTIC EXPOSURE: A NOVEL LINK TO GOUTY ARTHRITIS
,
M. Wang, Y. Liu, X. Meng, S. Zhong, W. Zhu, Y. Pan
2026 OP0296
EFFECTS OF CAUSAL BELIEFS ABOUT GOUT ON VIEWS ABOUT GOUT MANAGEMENT: A RANDOMISED EXPERIMENTAL STUDY
,
R. Murdoch, B. Mihov, A. Horne, K. Petrie, G. Gamble, L. Fleck, N. Dalbeth
Goto page:
10
50
100
